CSG’s €17 Billion Order Book Faces Its Biggest Test as Stock Sinks on Fraud Claims

The Czechoslovak Group is living a tale of two realities. On one side, a record €17 billion backlog and a €3.8 billion IPO war chest. On the other, a stock that has cratered 65% from its January debut and now trades at a fraction of its offer price. The gap between operational strength and market confidence has rarely been wider — and the next two weeks will determine whether it closes or widens further.

Shares of the defence and industrial conglomerate dipped to a fresh 52-week low of €12.20 on Wednesday before staging a modest recovery to close Friday at €12.75, up slightly on the day but still nursing a monthly loss of roughly 28%. The selling pressure intensified after research firm Hunterbrook alleged that CSG had systematically overstated its production and manufacturing capacity. Chief executive Michal Strnad has forcefully rejected the claims, insisting all operational reports are accurate. But the damage to investor sentiment is already done.

The technical picture reflects the distress. The relative strength index sits at around 30, a level typically considered oversold and capable of attracting contrarian buyers. Yet the stock remains far below its 50-day moving average of €16.70, and annualised volatility has surged to nearly 60%. For any sustained turnaround, the shares would need to reclaim that moving average — a leap of more than 30% from current levels.

Should investors sell immediately? Or is it worth buying CSG?

Investors Split on Whether the Sell-Off Has Gone Too Far

The rout has fractured the shareholder base. Michal Semotan, who says he began buying at €17, views the current level as a recovery opportunity, betting that CSG’s presence in the hot defence sector will eventually vindicate a purchase at these prices. Investor Kejla disagrees, calling the IPO rushed and arguing that the original valuation failed to price in the risks now laid bare by the short seller attack.

The fundamental debate will come to a head on 7 August, when management releases half-year results. That report will need to show that the company can convert its enormous order flow into profit without margin compression or delivery delays. In the first quarter, revenue climbed to roughly €1.5 billion and operating profit rose nearly 9% year on year. Beyond that, CSG is in talks for additional contracts worth €27 billion, supported by a favourable political backdrop: the EU recently agreed new frameworks for defence investment, and NATO continues to push its ambitious spending targets.

The challenge for the board is to prove that the capacity figures challenged by Hunterbrook are real — and that the company’s execution can keep pace with the demand. Until an independent review of the disputed data is provided, the weight on the stock is unlikely to lift. For now, the €12.20 floor is the only line of defence, and the next few trading sessions will show whether it holds or breaks.

Ad

CSG Stock: New Analysis - 28 June

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSG’S | boerse | 69648301 |